On Connie’s very first day of her first cancer treatment, she read a story about Ernest Hemingway that was in a magazine in the treatment room. A quote from Hemingway stood out to her and she still has this quote in her home today. It read, “You won’t always win, but what is important is to put up a good fight. Never quit, never give up.” Read More
In the U.S. 1 in 3 women will develop cancer in their lifetime. REVLON partnered with CROWDRISE in a fundraising competition where organizations that support women’s health causes competed for cash prize donations from Revlon. The charity that raised the most money won a $1 Million dollar donation to their cause. During the challenge over $1.4 Million was given away in prize money to organizations participating in the Challenge.
Since the initial report of ACGT’s researchers success with CAR-T technology in 2012, there has been tremendous interest in the commercial development of the therapy, moving it from lab to practice. An October 3rd Report in Cell and Gene Therapy Insights reviews the current state of CAR-T therapeutics. Read More
In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, … Read More
“They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in,” Morrow said. Read More
I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More
Dr. Stephen Eck, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council, talks about the importance of personalized therapies for cancer. “Historically, we’ve tried … Read More
Dr. Michael Lotze, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council speaks about progress in the fight against cancer he has witnessed during his … Read More
2015 – 2016 ACGT Young Investigator, Yvonne Chen, MS, PhD, speaks about using engineered T-cells to cure leukemia in this video from May 2016. Great progress … Read More
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.